Please note: this product has been discontinued.
| Catalog # | Item name |
|---|---|
| KIT-NCOV-PP1-1000 | 2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2 |
Order now
Product info
Please note: this product was discontinued on September 30, 2021.
Learn more here.
Discontinuation FAQ Sheet.
Please see our ValuPanel™ oligonucleotides for recommended RUO alternatives for non-clinical testing:
- 2019-nCoV ValuPanel Reagents Separately delivered primers and probes that are the same as those found in the 2019-nCoV CDC-qualified Probe and Primer Kit. For Research Use Only. Not for use in diagnostic procedures.
- Influenza SARS-CoV-2 Multiplex ValuPanel Reagents. Separately delivered primers and probes that may be used for a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. For Research Use Only. Not for use in diagnostic procedures.
Resources
- Product insert
- Certificate of Analysis, Lot #143503
- Certificate of Analysis, Lot #143764
- Certificate of Analysis, Lot #144000
- Certificate of Analysis, Lot #144604
- CDC - 2019-nCoV Real-Time RT-PCR Diagnostic Panel - Fact Sheet for Healthcare Providers
- CDC - 2019-nCoV Real-Time RT-PCR Diagnostic Panel - Fact Sheet for Patients
- SDS for unlabeled oligos
- SDS for fluorescently-labeled oligos
Do you have any questions?
Recommended products
PCR reagents* including master mix and enzyme for SARS-CoV-2 assay development are also available
| Item name | |
|---|---|
|
sbeadex Pathogen Nucleic Acid Purification Kit |
View product |
| RapiDxFire 1-step RT-qPCR System | View product |
For a complete SARS-CoV-2 Quality Solution, consider the AccuPlex™ SARS-CoV-2 Verification Panel coupled with the AccuPlex™ SARS-CoV-2 Reference Material Kit from LGC SeraCare Life Sciences. The target sequence of interest is packaged into a stable non-infectious, and replication-deficient alphavirus particle and the products contain positive materials directed against the published CDC and WHO consensus sequences and the S gene. Also includes negative materials targeting the human RNase P gene.
What do you require to develop your SARS-CoV-2 assay?
We offer probes and primers specific to Coronavirus as well as enzymes, master mix, and extraction capabilities.
Related products
| Item name | |
|---|---|
| 2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2 | View product |
| US CDC 2019-nCoV ValuPanel Reagents* | View product |
| Charité 2019-nCoV BHQ ValuPanel Reagents* | View product |
| Charité 2019-nCoV BBQ-650 ValuPanel Reagents* | View product |
| Yale 2019-nCoV SalivaDirect ValuPanel Reagents* | View product |
*For Research Use Only. Not for use in diagnostic procedures.
References
Emergency Use Authorization Protocols and FAQs
- FDA’s current Emergency Use Authorizations (EUA) for IVDs: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC)
- CDC’s Instructions for Use (IFU): CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel
- FDA Guidance Document: Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency
- FDA’s FAQs: Diagnostic Testing for SARS-CoV-2
- CDC’s FAQs: Diagnostic Tools and Virus for COVID-19
Research Use Only COVID-19 Protocols, Primers, and Probes
- US CDC RUO probe and primer information: Research Use Only 2019-Novel Coronavirus (2019-nCoV) Real-time RT-PCR Primer and Probe Information
- WHO interim guidance for laboratory testing: Novel Coronavirus (COVID-19) technical guidance: Laboratory testing for COVID-19 in humans
